Day: September 16, 2022

Posted on

Ghana Marburg Outbreak Declared Over

The World Health Organization has declared an end to Ghana’s outbreak of the deadly Marburg virus after more than six weeks without any new cases.

Three cases of the virus were recorded in the West African country in late June, killing two people.

Marburg is a highly infectious viral hemorrhagic fever in the same family as Ebola. The symptoms of Marburg include diarrhea, fever, nausea and vomiting.

Speaking at a press conference Friday in Accra, head of the Ghana Health Service, Dr. Patrick Kuma-Aboagye, said having passed the mandatory 42-day period without a new case, the country is now free of the virus.

“I do hereby state that, the appropriate outbreak reasons to Marburg disease have been implemented during the 42 days, following the last negative PCR test result for the sole surviving patient with recommendation from WHO,” he said. “Ghana has, therefore, successfully interrupted the first Marburg virus disease outbreak and hereby declare that the outbreak is over.”

A total of 198 people were tested for the virus when it first broke in Ghana. They all tested negative.

It is the second time Marburg made a West African appearance. The first outbreak was in Guinea in September of last year.

Marburg has also appeared in Angola, the Democratic Republic of the Congo, Kenya, South Africa and Uganda.

There are no vaccines or antiviral treatments for Marburg, but WHO says supportive care — rehydration with oral or intravenous fluids — and treatment of specific symptoms improves the rate of survival.

Source: Voice Of America

Posted on

Canadian Researchers Developing Oral Insulin

Research to develop a pill form of insulin is showing promise at the University of British Columbia in western Canada. The goal is to eliminate the need for diabetics to inject themselves with the lifesaving medication.

According to the World Health Organization, there are an estimated 422 million diabetics worldwide. The disease claims 1.5 million lives each year. The U.S. Centers for Disease Control and Prevention estimates 30 million Americans have diabetes.

Although widely available in the developed world, current forms of insulin require refrigeration, which can be a stumbling block in developing nations.

An oral version of insulin, in the form of an everyday pill, could change everything, making it easier and cheaper to transport and distribute — even to remote regions of the planet.

Researchers at the University of British Columbia in Vancouver think they might have discovered a formula for a pill that effectively delivers a full dose of insulin to a patient’s liver — where it is needed to regulate blood sugar levels — without dissipating uselessly in the stomach.The trick is to not swallow the pill, according to Anubhav Pratap-Singh, an assistant professor at the school’s Faculty of Land and Food Systems and the project’s lead researcher. He said the pill can be absorbed in the mouth by wedging it between the cheek and gums. In laboratory studies on rats, full doses of insulin reached the liver, he said.

“So we are getting quite a high amount of yield and so we hope that this will be more economical,” Pratap-Singh said.

Pratap-Singh started studying oral insulin in 2018, inspired to help his diabetic father, who has to inject insulin multiple times a day. He said a pill form would increase the quality of life for millions of patients who use insulin around the world.

“Instead of having to take insulin and having to travel with it in refrigerated boxes, one will simply have [a] normal capsule or tablet in a normal wrapper, which will be shelf stable, and very, very affordable,” Pratap-Singh said.

Dr. Daniel Drucker is professor of medicine at the Lunenfeld-Tanenbaum Research Institute and the University of Toronto. He said previous attempts at oral insulin failed to efficiently deliver enough of the drug within the body. To compensate, huge pill doses were required that would have driven prices higher for the drug.

“We have to pay the manufacturing costs of a large amount of insulin in this case that never makes it into the body,” Drucker said.

Drucker said new insulin pumps, which act as an artificial pancreas, have become increasingly effective in treating diabetes. He also said the development of cell-based insulin replacement therapy, which would create beta cells that automatically release necessary insulin, look promising.

For Pratap-Singh and other researchers, the next steps involve years of further testing of what could be a revolutionary method of insulin delivery.

Source: Voice Of America

Posted on

EV Technology Group Announces Definitive Agreement to Acquire Portfolio of Iconic Automotive Brands of Ford, Maserati and Ferrari Coach Builders

Acquisition of brand portfolio further solidifies EV Technology Group’s mission of electrifying iconic brands

Marazzi, Fantuzzi, Brewster & Co and Officine Stampaggi Industriali – joining the EV Technology Group portfolio of strategic brands

Marazzi, Fantuzzi, Brewster & Co and Officine Stampaggi Industriali – joining the EV Technology Group portfolio of strategic brands

TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) — EV Technology Group Ltd. (the “Company” or “EV Technology Group”) (NEO: EVTG, OTCQB: EVTGF, DE: B96A) announces that it has entered into a share exchange agreement (the “Definitive Agreement”) with 1000310362 Ontario Inc. (the “Target”) and its shareholder, to acquire a portfolio of intellectual property including iconic brands Officine Stampaggi Industriali, Fantuzzi, Marazzi and Brewster & Co. (the “Transaction”).

EV Technology Group has a strategy of acquiring iconic, well loved automotive brands and then electrifying them for the future of motoring. This strategic transaction expands the portfolio of brands under EV Technology Group’s control and represents major potential to expand the future landscape of electric motoring. The brands in the acquisition represent the epitome of world-class design and heritage, giving EV Technology Group the ability to leverage on existing brand value, and offer unique luxury EVs, with existing charm and heritage, to customers across the globe. The brands in the Transaction include:

EV Technology Group 4 new brands

Marazzi, Fantuzzi, Brewster & Co and Officine Stampaggi Industriali – joining the EV Technology Group portfolio of strategic brands

Fantuzzi
Fantuzzi was founded in 1939 by Medardo Fantuzzi, an automotive engineer, in Modena Italy. Medardo and his brother Gino Fantuzzi were involved in building the Maserati A6GCS, Maserati 350S and Maserati 200S during the 1940’s and 1950’s. Medardo went on to work for Ferrari until 1966, where he became known for building bespoke low-production performance cars including the Ferrari Tipo 156 “sharknose” Fantuzzi, additionally working for De Tomaso, Scuderia Serenissima, AMS and Techno, emblematic designs that are still cherished today.

Marazzi 
Marazzi was founded by Carlo Marazzi and his two sons, Serafino and Mario in 1967, in Milan Italy. Marazzi first completed the Lamborghini 400GT 2+2 series, followed by a series of 125 Lamborghini Islero, and the first few of the Lamborghini Jarama. Then came the beautiful Alfa Romeo 33 Stradale.

Officine Stampaggi Industriali
Officine Stampaggi Industriali (OSI) was founded in 1960, by Luigi Segre, former president of Carrozzeria Ghia, and Arrigo Olivetti from Fergat. OSI was based in Turin Italy and was a short-lived company that produced custom built vehicles based on Alfa Romeo, Fiat and Ford. Although production was short, OSI made a lasting impression in the automotive industry, renowned for the conception of the 1960 Innocenti 950 Spider and the Ford 20M TS Coupé, few of which are still around today.

Brewster & Co
Brewster & Company dates back to 1810, when James Brewster quickly formed a reputation as America’s premier carriage maker. Brewster then went on to work on automobiles, with the first being ahead of the times with an electric car based on a gas-powered Delaunay-Belleville chassis in 1905. The Company was well-recognised in America as a supreme coachbuilder for a variety of vehicles, with an on-off relationship with Rolls-Royce. Brewster & Co paved its way in the bespoke vehicle industry, winning numerous awards.

Pursuant to the Definitive Agreement, EV Technology Group will issue a total of 1,950,000 common shares of the Company (the “Payment Shares”) to the shareholder of the Target in exchange for all of the issued and outstanding shares of the Target, with a number of the Payment Shares subject to contractual lock-up restrictions. No finder fees will be paid in connection with the Transaction.

Wouter Witvoet, CEO of EV Technology Group said, “EV Technology Group firmly believes in the future of electric vehicles, and currently the most efficient way to drive adoption is with the power of brands. By acquiring iconic vehicles, we take inspiration from the brand, including its design, values, heritage and ambition. This addition of four incredibly historic Companies within our portfolio is strategic and represents our trajectory to becoming one of the most prominent electric automotive brands of today.”

EV Technology Group
EV Technology Group was founded in 2021 with the vision to electrify iconic brands – and the mission to redefine the joy of motoring for the electric age. By acquiring iconic brands and bringing beloved motoring experiences to the electric age, EV Technology Group is driving the EV revolution forward. Backed by a diversified team of passionate entrepreneurs, engineers and driving enthusiasts, EV Technology Group creates value for its customers by owning the total customer experience — acquiring and partnering with iconic brands with significant growth potential in unique markets, and controlling end-to-end capabilities. To learn more visit: https://evtgroup.com/

Media
Rachael D’Amore
rachael@talkshopmedia.com
+1519-564-9850

Investor Relations
Dave Gentry
dave@redchip.com
+14074914498

EV Technology Group
Wouter Witvoet
CEO and Chairman of the Board
wouter@evtgroup.com

Forward-Looking Information

This news release contains forward-looking statements including, but not limited to: the closing of the Transaction and EV Technology Group operations, expectations, and future actions. Often, but not always, these Forward-looking Statements can be identified by the use of words such as “estimated”, “potential”, “open”, “future”, “assumed”, “projected”, “used”, “detailed”, “has been”, “gain”, “planned”, “reflecting”, “will”, “containing”, “remaining”, “to be”, or statements that events, “could” or “should” occur or be achieved and similar expressions, including negative variations.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any results, performance or achievements expressed or implied by the Forward-looking Statements, including those factors discussed under “Risk Factors” in the filing statement of the Company. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in Forward-looking Statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.

Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. The forward-looking statements contained herein are made as of the date hereof and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except where required by law. There can be no assurance that these forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

THE NEO STOCK EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1c9e71f1-de3f-469b-ae54-77a514882da9

Posted on

Forbes Measures the Impact of Public Institutions With Pomilio Blumm Commended as a Leading Communication Agency

At the Forbes Social Awards, Italian Company Pomilio Blumm With Offices Throughout Europe, is Commended as a Leading Communication Agency

Forbes rewards the best public communication initiatives at the four season hotel in Florence, Italy.

September 13, 2022 Firenze (Italy) news – Social Awards, Forbes rewards the best public communication initiatives at the four season hotel in Florence. In pic: Eike Schmidt

ROME, Sept. 16, 2022 (GLOBE NEWSWIRE) — The Forbes Social Awards showed the ever-increasing impact of public institutions on the health of society and economics. An impact made even more relevant if we consider the challenging times when this edition was held, after years of the Pandemic and after months of the war in Ukraine, meaning new problems for public institutions while the pre-existing ones are even more urgent, requesting new efforts for public communication and in the dialogue with citizens. Among the communication agencies, Pomilio Blumm had the lion’s share, thanks to its communication strategies which showed resilience in the new international reality for the EU. The Italian Agency is not new to such a feat, in a few years it has become the most commissioned agency in the EU, and is expanding also in other continents, with new offices and new projects. Pomilio Blumm is considered by the Financial Times among the fastest growing agencies, and recently announced a doubling turnover. To become one of the most important competitors in Europe for global institutional communication the company relies on advanced research centres, and has among its customers the European Central Bank, the EU Commission and the EU Parliament.

The institutions whose campaigns are “powered” by Pomilio Blumm are also the most interesting projects. EU-LISA, the European Union Agency for the Operational Management of Large-Scale IT Systems in the Area of Freedom, Security and Justice was awarded for the “innovative approach focused on the realisation of concrete digital information systems, producing multimedia applications as interactive publications […] to convert highly technical and complex concepts into appealing communication for the general public.”

The Italian Government (MAECI and ITA) was awarded for the nation branding campaign “Italy is simply extraordinary: beIT, promoting the ‘Made in Italy’ brand in support of Italian exports. It has a global dimension, putting Italy in the focus of an international public in original and innovative ways, and also Italy’s values and talents, its skills and its extraordinary potential. […] The project, based on the development of documentary and editorial content with an innovative profile, has involved exceptional testimonials, both from young talents and the most established stars, not least of them Giorgio Armani.”

DG NEAR, meaning Neighbourhood and Enlargement Negotiations, won the prize for the Young Europeans Ambassador Campaign in the Western Balkans “for the commitment to building this young and fresh team of people ready to make a real impact on EU-Balkan relations.” The G20 of Culture in Rome was also awarded, the summit on culture of the 20 largest economies in the world, for “the spectacular organisation of the Culture Ministerial Meeting, held in Rome, in an exceptional setting, in the centre of the Colosseum arena.” EFSA, the European Agency for Food Safety was awarded for the “One Conference, the product of an articulated and unified vision that took shape in Brussels by bringing together, under the helm of food safety, the visions of the main European agencies working on food and health safety.” EUIPO, the European Union Intellectual Property Office, was awarded for “its design awards, celebrated in the Dutch city of Eindhoven. The award raised awareness of the design protection system in the EU, and promotes design as a valuable intellectual property right that underpins the European economy.” Frontex, the European Border and Coast Guard Agency, was awarded for its activities; the agency promotes, coordinates and develops European border management in line with the EU fundamental rights charter and the concept of Integrated Border Management. A special mention was awarded to DGCOMM, for its super-partes inspiration of EU values to EU institutions.

The protagonist of the ceremony was Eike Schmidt, the director of the Uffizi in Florence, one of the most prominent museums in the world awarded for its communication. Schmidt explained the importance of Renaissance values for Europe and reminded how the mission of the museum in Florence is to have a “revolution in culture thanks to new methods of communication, but also a revolution in communication thanks to the artworks of our museum which we make come alive.”

For more information:

LaPresse SpA Communication and Press Office Director
Barbara Sanicola – barbara.sanicola@lapresse.it +39 02 26305578 M +39 333 3905243

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/16906946-ecc8-42b7-9f9a-4234b06f59a3

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Posted on

Wasder and Ultra Join Forces to Make Web3 Gaming More Accessible to Everyone

STOCKHOLM, Sept. 16, 2022 (GLOBE NEWSWIRE) — Global social gaming platform Wasder and Web3 gaming platform Ultra announced a strategic partnership today that will benefit both companies, as well as players and developers in the Web3 gaming space.

Wasder, a gamified social media where players can express themselves, connect with others, explore the world of games and earn rewards, and Ultra, a gaming platform that brings more value to games, digital assets and tournaments to one place, join forces to strengthen their offering in the Web3 gaming space. By providing both players and developers with a more seamless user experience, this partnership aims to make web3 gaming more accessible and rewarding to everyone.

In short, Ultra will gain access to the gamification feature of Wasder called the “Wasder season pass”, as well as all the social features of the platform. Meanwhile, Ultra will provide its Web3 games catalog to Wasder and direct in-app access to Ultra’s games store. This will make it easier for developers to market their games to relevant audiences and enable players to discover new games. Both companies will collaborate to support Web3 developers by introducing the other to their respective networks and services.

“This is a really exciting partnership that brings together two aspects of gaming that go hand in hand but have been worlds apart until now – games distribution and community management. We’re also looking forward to the synergies that this new relationship brings. It’s a great opportunity not only for Wasder and Ultra to become stronger together in this space, but game studios and players will also be able to reap the benefits as well,” says Thomas Gronnevik, CEO of Wasder. “We’re looking forward to featuring games by developers introduced by Ultra on the Wasder season pass. We might even feature Ultra as a brand on a separate season. And we’re more than happy to introduce our partners and their games to Ultra for distribution.”

“We’re thrilled to be partnering with Wasder and furthering our commitment to providing key solutions for players around the world. Ultra is built around the vision of making Web2 and Web3 gaming as accessible as possible over the years to come, and Ultra’s blockchain is designed with this very purpose in mind. We’ll be teaming up with Wasder to make games more discoverable for game developers and players, assisting in the integration of Ultra’s technology, hosting tournaments, and introducing relevant companies to Wasder,” says Nicolas Gilot, CO-CEO of Ultra.

Wasder is a social gaming platform with over 1.5 million downloads on the Google Play store. The Wasder season pass is the gamification of Wasder and rewards players for being friendly members of the Wasder community. Rewards include everything from digital stickers to in-game NFTs, and new rewards will be added over time. In collaboration with partners like Ultra, Wasder aims to create a fun and inclusive global gaming community open for everyone, regardless of who you are or what games you love to play.

Ultra is a gaming platform designed to provide a range of gaming-related apps all in one place. Ultra provides low distribution fees and tools to increase discoverability, monetization, and community building. Powered by Ultra’s powerful carbon-neutral certified blockchain, the Ultra platform gives players the opportunity to buy, sell, and trade games and in-game items with absolutely no added costs. The platform also houses a range of apps to play games, watch livestreams, and participate in tournaments, all from within the Ultra platform.

Press contact Wasder: Mads Jacobsen (mads@wasder.gg)

This content was issued through the press release distribution service at Newswire.com.

Posted on

Philips showcases clinical data and solutions designed to deliver better cardiac care with greater efficiency at TCT 2022

September 16, 2022

  • Global consensus data recommends the use of intravascular ultrasound (IVUS) in many peripheral vascular disease (PVD) procedures
  • Philips Engagement Hub at TCT to feature a range of physician-led discussions, in-depth symposia, and hands-on trainings that address some of today’s most pressing cardiology challenges

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest innovations and cardiology solutions designed to strengthen clinical confidence, build efficiency throughout the care pathway and improve cardiac care experiences at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (Boston, USA, September 16-19). In addition, the company will present key clinical data, including global consensus data which highlights the importance of IVUS for both arterial and venous procedures.

“At Philips, we are fully focused on supporting physicians to improve the health and well-being of the patients they serve. Some of the most ground-breaking work we are doing to achieve this is happening in cardiology,” said Chris Landon, General Manager, Image Guided Therapy Devices at Philips. “TCT attendees will have the opportunity to see first-hand our complete set of solutions designed to provide clinicians with the diagnostic and therapeutic devices they need to optimize the workflow and improve outcomes for each individual patient.”

An interactive cardiology experience with Philips at TCT 2022
Visitors to TCT 2022 will have access to Philips’ latest solutions, plus opportunities to engage with clinical experts and experience innovative cardiac solutions. Philips will be hosting hands on demonstrations, symposia and discussions on topics that range from how to start an ultra-low contrast PCI program, to amplifying gender equality in medicine. Visitors will also have the opportunity to learn more about Philips Azurion, the next generation image-guided therapy platform, Philips Interventional Applications Platform – IntraSight, which optimizes lab performance with its imaging, physiology and co-registration tools, and the Philips iFR (Instant Wave-free Ratio) with its evidence-based methodology that improves outcomes, saves time, and reduces patient discomfort. Philips iFR is the only resting index to earn a Class IA guideline recommendation from the ACC/AHA/SCAI and ESC based on clinical evidence of its accuracy [1, 2].

Philips’ latest technology advancements in diagnostic, interventional and monitoring solutions at TCT 2022 include:

  • Philips 3D Intracardiac Echocardiography Catheter – VeriSight Pro: Used with Philips’ premium cardiology ultrasound systems EPIQ CVx and CVxi, the VeriSight Pro offers superior 2D and 3D live-image guidance for a wide range of procedures in structural heart disease and electrophysiology.
  • Simplifying coronary and peripheral atherectomy and lead extraction procedures with Philips Laser System – Nexcimer: The only system compatible with catheters that have Level I clinical data for ISR atherectomy and that can also support lead extraction procedures (the removal of pacemaker or defibrillator leads around the heart) [3,4].
  • Philips live fluoroscopy-echo fusion imaging  – EchoNavigator 4.0: Used with the Philips Image Guided Therapy System – Azurion – and Philips’ premium cardiology ultrasound system – EPIQ CVxi, the new EchoNavigator Release 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transeptal guidance during minimally-invasive structural heart disease procedures.

Published clinical data presented at TCT 2022
IVUS consensus and large-scale, real-world data summary: On Saturday, September 17, at 11:30am ET in the Philips Engagement Hub,  Eric A. Secemsky, MD, Interventional Cardiologist at Beth Israel Deaconess Medical Center and Assistant Professor of Medicine at Harvard Medical School in Boston, MA, will review two critically important data sets released in late 2021 that highlight the importance of IVUS for both arterial and venous procedures, including the new consensus document from 30 global vascular experts, which recommends routine use of IVUS as a preferred imaging modality in all phases in many peripheral vascular disease (PVD) procedures, published in the August 2022 issue of the Journal of the American College of Cardiology: Cardiovascular Interventions as “Appropriate Use of Intravascular Ultrasound During Arterial and Venous Lower Extremity Interventions.”

New study validates ambulatory monitoring as a valuable, cost-neutral tool
Many patients with severe symptomatic aortic stenosis (SAS) are treated with a transcatheter aortic valve replacement (TAVR) – a minimally invasive procedure that replaces a diseased aortic valve with a prosthetic valve. As an alternative to open-heart aortic valve replacement surgery, TAVR treatment offers several benefits for symptomatic SAS patients, including reduced length of hospital stay and an increased likelihood of home discharge [5].

A recent study, “Costs and Outcomes of Mobile Cardiac Outpatient Telemetry Monitoring Post-Transcatheter Aortic Valve Replacement,” published in the August issue of the Journal of Comparative Effectiveness Research, examined the impact that using Philips MCOT (Mobile Cardiac Outpatient Telemetry) had on patient outcomes and value of high-quality care following TAVR procedures. The study revealed that MCOT-monitored TAVR hospital patients were more than 16% more likely to receive a permanent pacemaker through a scheduled physician referral than unmonitored patients (100% MCOT vs 83.5% non-MCOT), helping to avoid unplanned readmissions [6]. The study illustrates that prescribing MCOT to patients post-TAVR may provide an opportunity for improved health outcomes or cost savings by monitoring for arrhythmic disturbances, and, if detected, allowing for timely intervention via pacemaker and the avoidance of costly and dangerous emergency care.

For the full calendar of events, as well as general information about Philips’ presence at the show, visit www.philips.com/TCT. Visit the Philips Engagement Hub to experience innovative cardiac solutions and follow the #TCT2022 conversation on @PhilipsLiveFrom throughout the event.

Refer to full Philips Laser System device labeling and instructions for important safety information. Caution: Federal law restricts this device to sale by or on the order of a physician.

[1] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129.
[2] 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.
[3]  Philips Laser System Data Sheet Specifications.
[4] Dippel et al. Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-stent Restenosis: Initial ISR Results (2015). JACC 8(1): 92-101.
[5] Arora S, Strassle PD, Kolte D, et al. Length of stay and discharge disposition after transcatheter 283 versus surgical aortic valve replacement in the United States. Circ Cardiovasc Interv. 2018;11(9). 284 doi:10.1161/circinterventions.118.006929.
[6] Belinda A Mohr, PhD1, et al. Impact of Mobile Cardiac Outpatient Telemetry Post-Transcatheter Aortic Valve Replacement on Costs and Outcomes: A Medicare Claims Analysis. J. Comp. Eff. Res. 2022.  https://www.futuremedicine.com/doi/10.2217/cer-2022-0112.

For further information, please contact:

Joost Maltha
Philips Global Press Office
Tel.: +31 610 558116
E-mail: joost.maltha@philips.com

Fabienne van der Feer
Philips Image Guided Therapy
Tel: + 31 622 698 001
E-mail: fabienne.van.der.feer@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment, and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Posted on

Adrian Ridge Named Executive Vice President Operations & Manufacturing for Nikkiso Clean Energy and Industrial Gases Group

TEMECULA, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Adrian Ridge has been named Executive Vice President, Operations &Manufacturing.

Adrian is a seasoned international executive with 30 years of experience with Atlas Copco in various leadership roles ranging from Service Management, Product Marketing Management, General Management and Global President of both Service and Prime equipment divisions. He is a Mechanical Engineer with an MBA in international Business.

Having global responsibility for more than 20 years and being based in the UK, Ireland, Japan, Spain and Belgium, he brings a deep understanding of the challenges the Group will face as they continue to grow their international footprint. In this role Adrian will lead global operations, directing the Group’s Functional Unit Presidents and General Managers to further develop and enhance their global manufacturing strategy and operational excellence management system. He will also focus on the customer experience, supply chain management, quality assurance and support of the Group’s global initiatives.

“Adrian is passionate about developing operations that deliver a ‘superior customer experience’,” according to Peter Wagner, CEO of Nikkiso CE&IG. “He is looking forward to joining CE&IG’s mission ‘to provide innovative equipment, technologies and services through our global group of companies to help our customers make a difference!’”

He will be based in Belgium and travel extensively to the Group’s key global operating locations. With this addition, Nikkiso continues their commitment to be both a global and local presence for their customers.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture, and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.), and process plants for Industrial Gases, Natural gas Liquefaction (LNG), Hydrogen Liquefaction (LH2) and Organic Rankine Cycle for Waste Heat Recovery. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com